Emerging paradigms in arterial thrombosis.

Area of Science:

• Cardiovascular Biology
• Hematology
• Molecular Medicine

Background:

• Traditional arterial thrombosis models focus on vessel injury, platelet activation, and coagulation.
• This paradigm explains platelet adhesion, activation, thrombin generation, and fibrin formation.
• Emerging evidence reveals a more complex and dynamic nature of arterial thrombosis.

Purpose of the Study:

• To review the traditional understanding of arterial thrombosis.
• To incorporate newly identified mediators into the thrombosis framework.
• To highlight potential pharmacologic targets for thrombosis intervention.

Main Methods:

• Literature review of established and emerging thrombosis research.
• Analysis of novel triggers, templates, and facilitators of thrombosis.
• Evaluation of the role of these mediators in disease states versus physiologic hemostasis.

Main Results:

• Established pathways involve collagen, tissue factor, platelets, and coagulation proteins.
• Novel mediators include cell-free nucleic acids, histones, DNA-histone complexes, polyphosphates, and microvesicles.
• These novel factors appear critical in disease-dependent thrombosis, not normal hemostasis.

Conclusions:

• Arterial thrombosis is a complex process involving traditional and novel mediators.
• Newly identified factors are crucial in acquired thrombotic conditions.
• These disease-specific mediators represent promising targets for pharmacological therapies.